Key result
In smokers with COPD, a reduction in estimated left ventricle epicardial volume was associated with lower all-cause mortality (HR 1.07; 95% CI 1.05-1.09).
Why the study?
Smokers with COPD have smaller LVs due to reduced preload, but less is known about the contribution of skeletal muscle wasting to LV size.
Is smaller left ventricle epicardial volume on noncontrast CT associated with lower mortality in patients with COPD?
Observational (n=2,423)
Is smaller left ventricle epicardial volume on noncontrast CT associated with lower mortality in patients with COPD?
Hazard Ratio: 1.07 (95% CI 1.05–1.09)
Smaller left ventricular epicardial volume measured on noncontrast chest CT is associated with lower all-cause mortality in patients with COPD.
Background Smokers with chronic obstructive pulmonary disease (COPD) have smaller left ventricles (LVs) due to reduced preload. Skeletal muscle wasting is also common in COPD, but less is known about its contribution to LV size. Purpose To explore the relationships between CT metrics of emphysema, venous vascular volume, and sarcopenia with the LV epicardial volume (LVEV) (myocardium and chamber) estimated from chest CT images in participants with COPD and then to determine the clinical relevance of the LVEV in multivariable models, including sex and anthropomorphic metrics. Materials and Methods The COPDGene study (ClinicalTrials.gov identifier: NCT00608764) is an ongoing prospective longitudinal observational investigation that began in 2006. LVEV, distal pulmonary venous blood volume for vessels smaller than 5 mm2 in cross section (BV5), CT emphysema, and pectoralis muscle area were retrospectively extracted from 3318 nongated, unenhanced COPDGene CT scans. Multivariable linear and Cox regression models were used to explore the association between emphysema, venous BV5, pectoralis muscle area, and LVEV as well as the association of LVEV with health status using the St George’s Respiratory Questionnaire, 6-minute walk distance, and all-cause mortality. Results The median age of the cohort was 64 years (interquartile range, 57–70 years). Of the 2423 participants, 1806 were men and 617 were African American. The median LVEV between Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 and GOLD 4 COPD was reduced by 13.9% in women and 17.7% in men (P < .001 for both). In fully adjusted models, higher emphysema percentage (β = –4.2; 95% confidence interval [CI]: –5.0, −3.4; P < .001), venous BV5 (β = 7.0; 95% CI: 5.7, 8.2; P < .001), and pectoralis muscle area (β = 2.7; 95% CI: 1.2, 4.1; P < .001) were independently associated with reduced LVEV. Reductions in LVEV were associated with improved health status (β = 0.3; 95% CI: 0.1, 0.4) and 6-minute walk distance (β = –12.2; 95% CI: –15.2, –9.3). These effects were greater in women than in men. The effect of reduced LVEV on mortality (hazard ratio: 1.07; 95% CI: 1.05, 1.09) did not vary by sex. Conclusion In women more than men with chronic obstructive pulmonary disease, a reduction in the estimated left ventricle epicardial volume correlated with a loss of pulmonary venous vasculature, greater pectoralis muscle sarcopenia, and lower all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Washko et al. (2020) conducted an observational in Chronic obstructive pulmonary disease (COPD) (n=2,423). Reduced left ventricle epicardial volume was evaluated on All-cause mortality (HR 1.07, 95% CI 1.05-1.09). In smokers with COPD, a reduction in estimated left ventricle epicardial volume was associated with lower all-cause mortality (HR 1.07; 95% CI 1.05-1.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: